Category: MasterClass

Master Class Faculty  – not to be added to Conference speakers/home page

Posted on by

Sean Berman

image of Sean Berman

Sean Berman attended Amherst College where he majored in English and Pre-Medical studies while playing quarterback for the football team. Upon graduation, he enrolled in the Masters of Science Biology program at Louisiana Tech University where he also utilized his last year of NCAA eligibility and played quarterback for head football coach Skip Holtz. Berman began his thesis work studying concussions where he developed a new laboratory methodology for studying blast induced traumatic brain injuries (TBI) in rats. He later went on to demonstrate and publish on the efficacy of treating TBI with the intravenous administration of adult adipose derived stem cells. He currently works with the Cell Surgical Network, a team of international physicians, studying the clinical application of stem cells and regenerative medicine. Sean has peer review published papers in neuroscience and has developed IRB approved protocols for investigating the use of cell therapy to mitigate TBI as well as PTSD in soldiers exposed to blast explosions with the United States Air Force.

Posted on by

Robert Hariri, MD, PhD

image of Robert Hariri

Robert Hariri, MD PhD Dr. Bob Hariri is an accomplished surgeon, biomedical scientist, and serial entrepreneur in two technology sectors, biomedicine and aerospace. He is the chairperson, founder, and chief executive officer of Celularity, Inc., one of the world’s leading human cellular therapeutics companies. Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases and continues today to make transformative contributions in the fields of immuno-oncology  and cell therapeutics along with tissue engineering and functional regeneration. He is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor(TNF). Dr. Hariri and his team of scientists were the first to obtain FDA approval to use its cryo preserved allogeneic, off-the-shelf Natural Killer (NK) cell therapy to treat COVID-19infected adults. He has authored over 150 published chapters, articles, and abstracts. When he is not in the laboratory or the corporate boardroom, Dr. Hariri is a jet-rated commercial pilot with thousands of hours of flight time in over 60 different military and civilian aircraft. He has also produced several feature films, as well as documentaries on global societal issues

 

Posted on by

Peter Diamandis, MD, PhD

Dr. Peter Diamandis

Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world’s leaders on exponentially growing technologies.

He earned degrees in molecular genetics and aerospace engineering from MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “The best way to predict the future is to create it yourself.”